Form 4: Procter & Gamble Executive Ma. Fatima Francisco Reports Stock Option Grant
SEC Form 4 Filing
Ma. Fatima Francisco, a Procter & Gamble executive, reported the acquisition of stock options and changes in beneficial ownership of common stock.
Summary
- On October 1, 2024, Ma. Fatima Francisco, CEO Baby, Fem & Family Care at Procter & Gamble, reported transactions related to Procter & Gamble Co [PG] securities.
- Francisco acquired 55,670 stock options with an exercise price of $173.04, exercisable from October 1, 2027, and expiring on September 29, 2034.
- The report also details direct ownership of 13,721.3362 shares of common stock and indirect ownership of 14,970.5057 shares through a retirement plan trustee, and 2,709.7713 shares by spouse and retirement plan trustees.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, and the sentiment is neutral. It reflects routine transactions related to executive compensation.
Positives
- The acquisition of stock options aligns the executive's interests with the company's long-term performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates changes in the holdings of a key executive at Procter & Gamble.
Comparison to Industry Standards
- Stock option grants are a common form of executive compensation in large, publicly traded companies like Procter & Gamble.
- The size of the grant and the vesting schedule are typical for executives at this level.
- Comparing the exercise price and vesting schedule to similar grants at companies like Unilever or Nestle would provide further context.
Stakeholder Impact
- The stock option grant aligns the executive's interests with shareholders, potentially incentivizing actions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 10/01/2024 | Date of earliest transaction (stock option acquisition). |
| 10/01/2027 | Date stock options become exercisable. |
| 09/29/2034 | Expiration date of stock options. |
| 10/03/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.